Deep Functional Phenotyping of the ALA Lung Health Cohort (NCT06177717)
The American Lung Association (ALA) Deep Phenotyping Ancillary Study of the Lung Health Cohort (LHC)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims to answer are whether people's bodies, environment, and general lung health are associated with: * the structure of the participants lungs' airways, * the structure of blood vessels in the participants lungs and heart, and * the participants lungs' ability to exchange gases. Participants will take four different lung function tests to measure lung function, including: * air movement in the lungs (oscillometry) * lung size (slow vital capacity (SVC) and functional residual capacity (FRC) * gas transfer in the lungs (diffusing capacity for carbon monoxide (DLCO).
Who can join: Review the eligibility criteria below.
Location: University of Alabama — Birmingham, Alabama
Age range: 25 Years to 35 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- University of Alabama — Birmingham, Alabama
- University of California, Los Angeles — Los Angeles, California
- National Jewish Health — Denver, Colorado
- Nemours Children's Jacksonville — Jacksonville, Florida
- Northwestern University — Chicago, Illinois
- University of Kansas — Kansas City, Kansas
- Johns Hopkins University — Baltimore, Maryland
- University of Michigan — Ann Arbor, Michigan
- Duke University — Durham, North Carolina
- Wake Forest School of Medicine — Winston-Salem, North Carolina
- University of Pittsburgh - Emphysema/COPD Research Center — Pittsburgh, Pennsylvania
- University of Vermont — Burlington, Vermont
📞 Contact the Study Coordinator
Phone: (410) 955-3467
Email: mmccor16@jhmi.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Diseases
- CF Bronchodilation — Vancouver, British Columbia
- Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers — Tampa, Florida
- Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting — Forney, Texas
- Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients — Miami, Florida
- Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study. — Montreal, Quebec
- Cough Capture as a Portal Into the Lung — The Bronx, New York
Explore by condition: All Lung Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.